PDF

Pillbox Organizers are Associated with Improved Adherence to HIV Antiretroviral Therapy and Viral Suppression: A Marginal Structural Model Analysis. (with Yue Wang, Mark van der Laan, David Guzman, Elise Riley, and David Bangsberg), Clinical Infectious Diseases (2007)

PDF

Assessing the Effectiveness of Antiretroviral Adherence Interventions: Using Marginal Structural Models to Replicate the Findings of Randomized Controlled Trials. (with Yue Wang, Mark J. van der Laan, and David R. Bangsberg), JAIDS (2006)

PDF

Adherence to antiretroviral therapy: a qualitative study with physicians from Rio de Janeiro, Brazil. (with Monica Malta, Scott Claire, Fernando Freitas, and Francisco I. Bastos), Cadernos de Saúde Pública (2005)

PDF

Hospital-based surveillance of meningococcal meningitis in Salvador, Brazil (with Soraia Cordeiro, Alan Neves, Cassio Ribeiro, Edilane Gouveira, Guilherme Ribeiro, Tatiana Lobo, Joice Reis, Katia Salgado, Mittermeyer Reis, and Albert Ko), Transactions of the Royal Society of Tropical Medicine and Hygiene (2007)

PDF

Assessing Needle Exchange Operations in a Poor Brazilian Community. (with Francisco I. Bastos, Mariana A. Hacker, Monica Malta, Mirtha Sudbrack, Marcia Columbo, and Waleska T. Caiffa), Substance Use and Misuse (2006)

PDF

Assessing HIV resistance in developing countries: Brazil as a case study. (with Marie-Claude Boily and Francisco I. Bastos), Rev Panam Salud Publica (2006)

The healthcare system and HIV epidemic in Brazil. (with Claudia Travassos, Francisco I. Bastos, Mariana Hacker, Eduard J. Beck, and Jose Carvalho de Noronha), The HIV Pandemic: local and global implications. (2005)

PDF

Adherence to antiretroviral therapy: a qualitative study with physicians from Rio de Janeiro, Brazil. (with Monica Malta, Scott Claire, Fernando Freitas, and Francisco I. Bastos), Cadernos de Saúde Pública (2005)

Management of HIV/AIDS: The Brazilian experience. (with Francisco I. Bastos, Diane Kerrigan, and Marie-Claude Bioly), Antiretroviral treatment: Experiences and challenges. [In French] (2004)

PDF

Highly active antiretroviral therapy in Brazil: The challenge of universal access in a context of social inequality. (with Mariana A. Hacker, Melissa Enriquez, and Francisco I. Bastos), Rev Panam Salud Publica (2004)

PDF

Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil. (with Guilherme S. Ribeiro, Joice N. Reis, Soraia M. Cordeiro, Josilene BT Lima, Edilane L. Gouveia, Katia Salgado, Hagamenon R. Silva, Rosemeire C. Zanella, Samanta CG Almeida, Maria C. Brandileone, Mitermayer G. Reis, and Albert I. Ko), Journal of Infectious Diseases (2003)

PDF

Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification (with Mark J. van der Laan, Napravnik Sonia, Joseph J. Eron, Richard G. Moore, and Steven G. Deeks), AIDS (2008)

PDF

History-Adjusted Marginal Structural Models to Estimate Time-Varying Effect Modification (with Steven Deeks, Jefferey Martin, and Mark van der Laan), American Journal of Epidemiology (2007)

PDF

Pillbox Organizers are Associated with Improved Adherence to HIV Antiretroviral Therapy and Viral Suppression: A Marginal Structural Model Analysis. (with Yue Wang, Mark van der Laan, David Guzman, Elise Riley, and David Bangsberg), Clinical Infectious Diseases (2007)

PDF

Virologic Efficacy of Boosted Double vs. Boosted Single Protease Inhibitor Therapy. (with Yue Wang, Mark van der Laan, Soo-Yon Rhee, Robert Shafer, and W. Jefferey Fessel), AIDS (2007)

PDF

Assessing the Effectiveness of Antiretroviral Adherence Interventions: Using Marginal Structural Models to Replicate the Findings of Randomized Controlled Trials. (with Yue Wang, Mark J. van der Laan, and David R. Bangsberg), JAIDS (2006)

PDF

History-Adjusted Marginal Structural Models and Statically-Optimal Dynamic Treatment Regimens (with Mark J. van der Laan and Marshall M. Joffe), The International Journal of Biostatistics (2006)

PDF

Estimation of direct causal effects. (with Sandra E. Sinisi and Mark J. van der Laan), Epidemiology (2006)

PDF

Individualized treatment rules: Generating candidate clinical trials (with Steven G. Deeks and Mark J. van der Laan), Statistics in Medicine (2007)

PDF

Assessing the Effectiveness of Antiretroviral Adherence Interventions: Using Marginal Structural Models to Replicate the Findings of Randomized Controlled Trials. (with Yue Wang, Mark J. van der Laan, and David R. Bangsberg), JAIDS (2006)

Link

Estimation of Direct and Indirect Causal Effects in Longitudinal Studies (with Mark J. van der Laan), U.C. Berkeley Division of Biostatistics Working Paper Series (2004)

PDF

Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial. (with Hans Steiner, Kirti Saxena, Sekou Ford, and Zekee Matthews), Journal of clinical Psychiatry (2003)

PDF

History-Adjusted Marginal Structural Models to Estimate Time-Varying Effect Modification (with Steven Deeks, Jefferey Martin, and Mark van der Laan), American Journal of Epidemiology (2007)

PDF

Hospital-based surveillance of meningococcal meningitis in Salvador, Brazil (with Soraia Cordeiro, Alan Neves, Cassio Ribeiro, Edilane Gouveira, Guilherme Ribeiro, Tatiana Lobo, Joice Reis, Katia Salgado, Mittermeyer Reis, and Albert Ko), Transactions of the Royal Society of Tropical Medicine and Hygiene (2007)

PDF

Assessing the Effectiveness of Antiretroviral Adherence Interventions: Using Marginal Structural Models to Replicate the Findings of Randomized Controlled Trials. (with Yue Wang, Mark J. van der Laan, and David R. Bangsberg), JAIDS (2006)

PDF

History-Adjusted Marginal Structural Models and Statically-Optimal Dynamic Treatment Regimens (with Mark J. van der Laan and Marshall M. Joffe), The International Journal of Biostatistics (2006)

PDF

Assessing Needle Exchange Operations in a Poor Brazilian Community. (with Francisco I. Bastos, Mariana A. Hacker, Monica Malta, Mirtha Sudbrack, Marcia Columbo, and Waleska T. Caiffa), Substance Use and Misuse (2006)

PDF

Assessing HIV resistance in developing countries: Brazil as a case study. (with Marie-Claude Boily and Francisco I. Bastos), Rev Panam Salud Publica (2006)

PDF

Estimation of direct causal effects. (with Sandra E. Sinisi and Mark J. van der Laan), Epidemiology (2006)

The healthcare system and HIV epidemic in Brazil. (with Claudia Travassos, Francisco I. Bastos, Mariana Hacker, Eduard J. Beck, and Jose Carvalho de Noronha), The HIV Pandemic: local and global implications. (2005)

Management of HIV/AIDS: The Brazilian experience. (with Francisco I. Bastos, Diane Kerrigan, and Marie-Claude Bioly), Antiretroviral treatment: Experiences and challenges. [In French] (2004)

Link

Estimation of Direct and Indirect Causal Effects in Longitudinal Studies (with Mark J. van der Laan), U.C. Berkeley Division of Biostatistics Working Paper Series (2004)

PDF

Highly active antiretroviral therapy in Brazil: The challenge of universal access in a context of social inequality. (with Mariana A. Hacker, Melissa Enriquez, and Francisco I. Bastos), Rev Panam Salud Publica (2004)

PDF

Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil. (with Guilherme S. Ribeiro, Joice N. Reis, Soraia M. Cordeiro, Josilene BT Lima, Edilane L. Gouveia, Katia Salgado, Hagamenon R. Silva, Rosemeire C. Zanella, Samanta CG Almeida, Maria C. Brandileone, Mitermayer G. Reis, and Albert I. Ko), Journal of Infectious Diseases (2003)

PDF

Biomarker discovery using targeted maximum-likelihood estimation: Application to the treatment of antiretroviral-resistant HIV infection (with Oliver Bembom, Soo-Yon Rhee, W Jeffrey Fessel, Sandra E. Sinisi, Robert W. Shafer, and Mark J. van der Laan), Statstics in Medicine (2008)

PDF

Direct Effect Models (with Mark J. van der Laan), International Journal of Biostatistics (2008)

PDF

Cross-validated Bagged Learning (with Annette Molinaro, Sandra E. Sinisi, and Mark J. van der Laan), Journal of Multivariate Analysis (2007)

PDF

Statistical Learning of Origin-Specific Statically Optimal Individualized Treatment Rules (with Mark J. van der Laan), International Journal of Biostatistics (2007)

PDF

Causal Effect Models for Realistic Individualized Treatment and Intention to Treat Rules (with Mark J. van der Laan), International Journal of Biostatistics (2007)

PDF

Assessing the Effectiveness of Antiretroviral Adherence Interventions: Using Marginal Structural Models to Replicate the Findings of Randomized Controlled Trials. (with Yue Wang, Mark J. van der Laan, and David R. Bangsberg), JAIDS (2006)

PDF

History-Adjusted Marginal Structural Models and Statically-Optimal Dynamic Treatment Regimens (with Mark J. van der Laan and Marshall M. Joffe), The International Journal of Biostatistics (2006)

PDF

Identifying important explanatory variables for time-varying outcomes. (with Oliver Bembom and Mark J. van der Laan), Fundamentals of Data Mining in Genomics and Proteomics (2006)

PDF

Estimation of direct causal effects. (with Sandra E. Sinisi and Mark J. van der Laan), Epidemiology (2006)

PDF

Biomarker discovery using targeted maximum-likelihood estimation: Application to the treatment of antiretroviral-resistant HIV infection (with Oliver Bembom, Soo-Yon Rhee, W Jeffrey Fessel, Sandra E. Sinisi, Robert W. Shafer, and Mark J. van der Laan), Statstics in Medicine (2008)

PDF

Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification (with Mark J. van der Laan, Napravnik Sonia, Joseph J. Eron, Richard G. Moore, and Steven G. Deeks), AIDS (2008)

PDF

History-Adjusted Marginal Structural Models to Estimate Time-Varying Effect Modification (with Steven Deeks, Jefferey Martin, and Mark van der Laan), American Journal of Epidemiology (2007)

PDF

Individualized treatment rules: Generating candidate clinical trials (with Steven G. Deeks and Mark J. van der Laan), Statistics in Medicine (2007)

PDF

Pillbox Organizers are Associated with Improved Adherence to HIV Antiretroviral Therapy and Viral Suppression: A Marginal Structural Model Analysis. (with Yue Wang, Mark van der Laan, David Guzman, Elise Riley, and David Bangsberg), Clinical Infectious Diseases (2007)

PDF

Virologic Efficacy of Boosted Double vs. Boosted Single Protease Inhibitor Therapy. (with Yue Wang, Mark van der Laan, Soo-Yon Rhee, Robert Shafer, and W. Jefferey Fessel), AIDS (2007)

PDF

Statistical Learning of Origin-Specific Statically Optimal Individualized Treatment Rules (with Mark J. van der Laan), International Journal of Biostatistics (2007)

PDF

Causal Effect Models for Realistic Individualized Treatment and Intention to Treat Rules (with Mark J. van der Laan), International Journal of Biostatistics (2007)

PDF

Assessing the Effectiveness of Antiretroviral Adherence Interventions: Using Marginal Structural Models to Replicate the Findings of Randomized Controlled Trials. (with Yue Wang, Mark J. van der Laan, and David R. Bangsberg), JAIDS (2006)

PDF

History-Adjusted Marginal Structural Models and Statically-Optimal Dynamic Treatment Regimens (with Mark J. van der Laan and Marshall M. Joffe), The International Journal of Biostatistics (2006)

PDF

Identifying important explanatory variables for time-varying outcomes. (with Oliver Bembom and Mark J. van der Laan), Fundamentals of Data Mining in Genomics and Proteomics (2006)

PDF

Assessing Needle Exchange Operations in a Poor Brazilian Community. (with Francisco I. Bastos, Mariana A. Hacker, Monica Malta, Mirtha Sudbrack, Marcia Columbo, and Waleska T. Caiffa), Substance Use and Misuse (2006)

PDF

Assessing HIV resistance in developing countries: Brazil as a case study. (with Marie-Claude Boily and Francisco I. Bastos), Rev Panam Salud Publica (2006)

The healthcare system and HIV epidemic in Brazil. (with Claudia Travassos, Francisco I. Bastos, Mariana Hacker, Eduard J. Beck, and Jose Carvalho de Noronha), The HIV Pandemic: local and global implications. (2005)

PDF

Adherence to antiretroviral therapy: a qualitative study with physicians from Rio de Janeiro, Brazil. (with Monica Malta, Scott Claire, Fernando Freitas, and Francisco I. Bastos), Cadernos de Saúde Pública (2005)

Management of HIV/AIDS: The Brazilian experience. (with Francisco I. Bastos, Diane Kerrigan, and Marie-Claude Bioly), Antiretroviral treatment: Experiences and challenges. [In French] (2004)

PDF

Highly active antiretroviral therapy in Brazil: The challenge of universal access in a context of social inequality. (with Mariana A. Hacker, Melissa Enriquez, and Francisco I. Bastos), Rev Panam Salud Publica (2004)

PDF

Biomarker discovery using targeted maximum-likelihood estimation: Application to the treatment of antiretroviral-resistant HIV infection (with Oliver Bembom, Soo-Yon Rhee, W Jeffrey Fessel, Sandra E. Sinisi, Robert W. Shafer, and Mark J. van der Laan), Statstics in Medicine (2008)

PDF

Direct Effect Models (with Mark J. van der Laan), International Journal of Biostatistics (2008)

PDF

Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification (with Mark J. van der Laan, Napravnik Sonia, Joseph J. Eron, Richard G. Moore, and Steven G. Deeks), AIDS (2008)

PDF

History-Adjusted Marginal Structural Models to Estimate Time-Varying Effect Modification (with Steven Deeks, Jefferey Martin, and Mark van der Laan), American Journal of Epidemiology (2007)

PDF

Individualized treatment rules: Generating candidate clinical trials (with Steven G. Deeks and Mark J. van der Laan), Statistics in Medicine (2007)

PDF

Statistical Learning of Origin-Specific Statically Optimal Individualized Treatment Rules (with Mark J. van der Laan), International Journal of Biostatistics (2007)

PDF

Causal Effect Models for Realistic Individualized Treatment and Intention to Treat Rules (with Mark J. van der Laan), International Journal of Biostatistics (2007)

PDF

Assessing the Effectiveness of Antiretroviral Adherence Interventions: Using Marginal Structural Models to Replicate the Findings of Randomized Controlled Trials. (with Yue Wang, Mark J. van der Laan, and David R. Bangsberg), JAIDS (2006)

PDF

History-Adjusted Marginal Structural Models and Statically-Optimal Dynamic Treatment Regimens (with Mark J. van der Laan and Marshall M. Joffe), The International Journal of Biostatistics (2006)

PDF

Identifying important explanatory variables for time-varying outcomes. (with Oliver Bembom and Mark J. van der Laan), Fundamentals of Data Mining in Genomics and Proteomics (2006)

Link

Estimation of Direct and Indirect Causal Effects in Longitudinal Studies (with Mark J. van der Laan), U.C. Berkeley Division of Biostatistics Working Paper Series (2004)

PDF

Biomarker discovery using targeted maximum-likelihood estimation: Application to the treatment of antiretroviral-resistant HIV infection (with Oliver Bembom, Soo-Yon Rhee, W Jeffrey Fessel, Sandra E. Sinisi, Robert W. Shafer, and Mark J. van der Laan), Statstics in Medicine (2008)

PDF

Direct Effect Models (with Mark J. van der Laan), International Journal of Biostatistics (2008)

PDF

Individualized treatment rules: Generating candidate clinical trials (with Steven G. Deeks and Mark J. van der Laan), Statistics in Medicine (2007)

PDF

Cross-validated Bagged Learning (with Annette Molinaro, Sandra E. Sinisi, and Mark J. van der Laan), Journal of Multivariate Analysis (2007)

PDF

Statistical Learning of Origin-Specific Statically Optimal Individualized Treatment Rules (with Mark J. van der Laan), International Journal of Biostatistics (2007)

PDF

Causal Effect Models for Realistic Individualized Treatment and Intention to Treat Rules (with Mark J. van der Laan), International Journal of Biostatistics (2007)

PDF

Super Learning: An Application to the Prediction of HIV-1 Drug Resistance (with Sandra E. Sinisi, Eric C. Polley, Soo-Yon Rhee, and Mark J. van der Laan), Statistical Applications in Genetics and Molecular Biology (2007)

PDF

History-Adjusted Marginal Structural Models and Statically-Optimal Dynamic Treatment Regimens (with Mark J. van der Laan and Marshall M. Joffe), The International Journal of Biostatistics (2006)

PDF

Identifying important explanatory variables for time-varying outcomes. (with Oliver Bembom and Mark J. van der Laan), Fundamentals of Data Mining in Genomics and Proteomics (2006)

PDF

Diagnosing Bias in the Inverse Probability of Treatment Weighted Estimator Resulting from Violation of Experimental Treatment Assignment (with Yue Wang, David Bangsberg, and Mark J. van der Laan), U.C. Berkeley Division of Biostatistics Working Paper Series (2006)

Link

Estimation of Direct and Indirect Causal Effects in Longitudinal Studies (with Mark J. van der Laan), U.C. Berkeley Division of Biostatistics Working Paper Series (2004)